This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Yan Chen, Ph.D.
Founder & Chief Executive Officer at Elpis Biopharmaceuticals


Founder and CEO. Yan brings more than 20 years of expertise in both mRNA display technology and biologic drug discovery in the oncology disease area. She was the Biotherapeutics Discovery Head at Juno Therapeutics and Senior Vice President of Research at X-Body Biosciences, where she co-invented dsDNA display technology, and acquired by Juno in 2015. Previously, she was an investigator and project leader in Oncology Biotherapeutics at Novartis Institutes for Biomedical Research. Earlier in her career, she was a scientist at Phylos and Adnexus playing instrumental roles in establishing the mRNA antibody and protein display technology platforms. Yan was a postdoctoral trainee in Immunology at Tufts Medical School and received her PhD in Immunology from National University of Singapore. She is the co-inventor of more than 20 patents in antibody technologies, biotherapeutics and cell therapy.

Agenda Sessions

  • Discovery of Tumor Targeting IL2Rb Agonist by mRNA Display Enabled Technology Platforms